TE Tirzepatide Editorial

Governance

Evidence and Verification Policy

Direct answer

Every factual claim on this site carries an evidence status: Verified, Partially verified, or Verification Pending. Status is determined by whether the underlying record has been checked against a primary source with a recorded date. Claims that cannot reach at least partial verification are not published as fact, and stale records are automatically suppressed or qualified.

Key takeaways

  • Three statuses govern every claim: Verified, Partially verified, and Verification Pending.
  • Primary sources outrank secondary reporting, which outranks provider marketing copy.
  • Stale prices, rankings, and availability claims are suppressed or qualified automatically.
  • Conflicting sources are shown as conflicting rather than silently resolved in favour of one.
  • Verification status is displayed on the page, not buried in a policy document.
Key facts
StatusesVerified · Partially verified · Verification Pending
Source hierarchyFDA labelling and primary literature > registry records > state boards > first-party capture > provider marketing
Staleness rulePrices older than the refresh window are qualified or suppressed
Conflict handlingShown as Conflicting Evidence; not silently resolved
DisplayStatus badge and dates on every page
Verified
Reviewed by Kim Callender, NP, FNP-BC
Published 2026-07-22
Editorially updated 2026-07-22
Fact verified 2026-07-22
Dataset snapshot 2026-07-22
Methodology v1.0

What does each evidence status mean?

Evidence statuses used across the site
StatusMeaningWhat may be published
VerifiedChecked against a primary source with a recorded dateThe claim, with its identifier or source and date
Partially verifiedSome elements confirmed, others outstandingConfirmed elements only; outstanding elements labelled
Verification PendingNot yet checked against a primary sourceNo factual assertion — the gap is shown instead

How are conflicting sources handled?

They are labelled as conflicting and both are shown. The temptation in a conflict is to pick the more plausible source and present it as settled, which produces a confident page built on an editorial guess. Where a provider's advertised price and its checkout differ, or where two records disagree, the disagreement is the finding.

Why does staleness matter as much as accuracy?

Because a price that was correct three months ago is now a claim about the present that nobody has checked. In a market where providers change pricing frequently, an undated correct-at-the-time figure functions as misinformation. Every price on this site carries its capture date, and figures past the refresh window are qualified or withheld.

How much of this site's data is actually verified?

Trials with full identifiers8Trials partially verified1Trials withheld pending audit1Providers with verified all-in price5Providers excluded with reason19Records
The published state of every dataset behind this site. Records that fail verification are excluded and counted here rather than being quietly estimated.
Data for: Verification state of the published datasets
GroupRecords
Trials with full identifiers8
Trials partially verified1
Trials withheld pending audit1
Providers with verified all-in price5
Providers excluded with reason19
Evidence statuses applied across every page and dataset
Evidence statusDefinitionWhat may be published
VerifiedChecked against a primary source with a recorded dateThe claim, with its identifier and date
Partially verifiedSome elements confirmed, others outstandingConfirmed elements only; the rest labelled
Verification PendingNot yet checked against a primary sourceNo factual assertion — the gap is shown

What does this page cover, and what does it deliberately leave out?

This page addresses Evidence statuses, hierarchy, staleness and conflicts and suppression, organised around the primary question of tirzepatide evidence policy. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.

Scope of this page and the basis for each element
ElementTreatment hereEvidence basis
Evidence statusesCovered on this pageRegulatory or policy source
HierarchyCovered on this pageRegulatory or policy source
StalenessCovered on this pageRegulatory or policy source
Conflicts and suppressionCovered on this pageRegulatory or policy source
Individualized clinical instructionDeliberately not coveredBelongs with the corrections process

What are the limits of what this page can tell you?

Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.

Specific limitations.
  • The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
  • Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
  • Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
  • Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.

What would change the conclusion on this page?

Any of the following would change what this page concludes:

  • New primary evidence bearing directly on tirzepatide evidence policy.
  • A change to FDA labelling affecting any statement made above.
  • A verified correction submitted through the corrections process and accepted on the evidence.
  • A material change to a captured record, including a price, term, or regulatory status.
  • Completion of a verification currently marked pending, which would replace a gap with a stated fact.

Frequently asked questions

What does Verification Pending mean?

The claim has not been checked against a primary source, so no factual assertion is made.

Which sources take priority?

FDA labelling and primary literature, then registry records and state boards, then first-party captures, and last provider marketing copy.

What happens to old prices?

They are qualified with their capture date or suppressed once past the refresh window.

What if two sources disagree?

Both are shown and the conflict is labelled rather than resolved silently.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?